GT
KYTH

Glenmede Trust’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Glenmede Trust’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$14K – 2910
2015
Q3 		$14K Hold
200
– – ﹤0.01% 2022
2015
Q2 		$15K Buy
+200
New +$10.7K ﹤0.01% 2002

Glenmede Trust's KYTH Position: Q4 2015 in Review

Glenmede Trust sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 200 shares — an estimated $14K sold.

Glenmede Trust first reported a position in KYTH in Q2 2015 and held it in 2 quarters. The position peaked at $15K in Q2 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Glenmede Trust reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Glenmede Trust sold 200 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $14K.
  • Glenmede Trust first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2015 and held it in 2 quarters.
  • Glenmede Trust's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $15K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.